Recursion Pharmaceuticals
RXRX
#3776
Rank
A$4.27 B
Marketcap
$10.94
Share price
5.36%
Change (1 day)
-31.14%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2023 (TTM): -$2.07

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.19. In 2022 the company made an earnings per share (EPS) of -$2.18 a decrease over its 2021 EPS that were of -$1.86.

EPS history for Recursion Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.07-4.84%
2022-$2.1817.39%
2021-$1.8650.85%
2020-$1.23